Mastocytosis: pathology, genetics, and current options for therapy (Q35994902)

11 August 2017

1 reference

title

Mastocytosis: pathology, genetics, and current options for therapy (English)

1 reference

11 August 2017

11

Dean D Metcalfe

1 reference

11 August 2017

Peter Valent

1

1 reference

11 August 2017

Cem Akin

2

1 reference

11 August 2017

Wolfgang R Sperr

3

1 reference

11 August 2017

Matthias Mayerhofer

4

1 reference

11 August 2017

Manuela Födinger

5

1 reference

11 August 2017

Robert Fritsche-Polanz

6

1 reference

11 August 2017

Karl Sotlar

7

1 reference

11 August 2017

Luis Escribano

8

1 reference

11 August 2017

Michel Arock

9

1 reference

11 August 2017

Hans-Peter Horny

10

1 reference

11 August 2017

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

46

1 reference

11 August 2017

1

1 reference

11 August 2017

35-48

1 reference

The growth and differentiation of mast cells

11 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

The riddle of the mast cell: kit(CD117)-ligand as the missing link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Mast cells and mast cell neoplasia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Classification and diagnosis of mastocytosis: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Clinical, genetic, and therapeutic insights into systemic mast cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Diagnosis and treatment of systemic mastocytosis: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Constitutively active mutant D816VKit induces megakayocyte and mast cell differentiation of early haemopoietic cells from murine foetal liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Mast cell disease associated with acute myeloid leukemia: detection of a new c-kit mutation Asp816His

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Variable expression of activation-linked surface antigens on human mast cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Detection of novel CD antigens on the surface of human mast cells and basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Clinical and histopathological aspects of cutaneous mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Bone marrow findings in systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Spleen findings in generalized mastocytosis. A clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Liver findings in generalized mastocytosis. A clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

The liver, spleen, and lymph nodes in mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Smouldering mastocytosis: a novel subtype of systemic mastocytosis with slow progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Significance of systemic mast cell disease with associated hematologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Diagnostic criteria and classification of mastocytosis: a consensus proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Tryptase a novel biochemical marker of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Cutaneous mastocytosis -- clinical heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Mast cell leukaemia: evidence for bone marrow origin of the pathological clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Mast cell leukemia: report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Mastocytosis: mediator-related signs and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Mastocytosis: current concepts in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Treatment of cutaneous mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Treatment of systemic mast cell disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Imatinib for systemic mast-cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Imatinib therapy in clonal eosinophilic disorders, including systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Treatment of systemic mast-cell disease with cladribine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Mast cell sarcoma of the larynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

Spleen colony-forming cell as common precursor for tissue mast cells and granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400010775

10.1080/10428190400010775

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference